Wyndham Hotels & Resorts, Inc. WH
Composite 45/100; the shares have moved about 32% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 24/100 — a strong mark against it.
Income ranks 68/100 — a moderate point in its favour. Quality ranks 67/100 — a moderate point in its favour. Valuation ranks 50/100 — a slight point in its favour.
Momentum ranks 24/100 — a strong mark against it. Balance-sheet strength ranks 28/100 — a moderate mark against it. Growth ranks 37/100 — a moderate mark against it.
What the company does Wyndham Hotels & Resorts is the world’s largest hotel franchisor by property count, with about 8,300 hotels across 100 countries and a leading presence in economy and midscale segments. Its portfolio includes 25 brands such as Super 8, Days Inn, La Quinta, and Wyndham, targeting everyday travelers.
Key financials Wyndham reports strong profitability metrics: ROE 39.4%, ROA 7.7%, and ROCE 11.3%. Gross, operating, and net margins stand at 62.8%, 47.7%, and 14.6%, respectively. Revenue growth is -5.5% while EPS growth is 20.4%. The dividend yield is 2.3% with a payout ratio of 60.9%.
Stock health The stock shows mixed momentum: -9.00% over 3 months, +5.69% over 6 months, and -13.41% over 12 months. It is -15.30% below its 52-week high, with an RSI(14) of 43.30. Sideravia scores Quality 67.9 and Income 74.8, but Growth and Strength lag at 36.2 and 28.3.
Price vs fair value The stock trades at a PREMIUM of 44.70% versus our fair-value estimate of 42.06 and at a discount of 29.38% versus the analyst 12-month target of 98.47. - Analysts remain bullish on long-term growth despite near-term international headwinds (CRE Daily). - Some outlets question valuation attractiveness relative to peers (StockStory). - A contrarian view suggests Wyndham’s yield may be compensating for perceived execution risks (Trefis).
Looking forward Forward P/E of 15.85 and PEG of 0.22 suggest potential value if growth reaccelerates. However, high leverage (Debt/Equity 5.57) and weak current ratio (0.99) warrant caution. Execution in international markets and brand revitalization will be key catalysts.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.